Abstract:AIM: To clone flagellin genes A (flaA) and B (flaB) from a clinical strain of Helicobacter pylori(Hpylori) and to construct prokaryotic expression systems of the genes and identify immunity of the fusion proteins.METHODS: The flaA and flaB genes from a clinical Hpylori isolate Y06 were amplified by high fidelity PCR. The nucleotide sequences of target DNA amplification fragments from the two genes were sequenced after T-A cloning. The recombinant expression vector pET32a inserted with flaA and flaB genes was constructed, respectively. The expressions of FlaA and FlaB fusion proteins in E. coli BL21DE3 induced by isopropylthio-p-D-galactoside (IPTG) at different concentrations were examined by SIDS-PAGE. Western blot using commercial antibodies against whole cell of H pylori and immunodiffusion assay using self-prepared rabbit antiserum against FlaA (rFlaA) or FlaB (rFlaB) recombinant proteins were applied to the determination of the fusion proteins immunity. ELISA was used to detect the antibodies against rFlaA and rFlaB in sera of 125 Hpylori infected patients and to examine rFlaA and rFlaB expression in 98 clinical isolates of H pylori, respectively.RESULTS: In comparison with the reported corresponding sequences, the nucleotide sequence homologies of the cloned flaA and flaB genes were from 96.28-97.13% and 96.31-97.73%, and their putative amino acid sequence homologies were 99.61-99.80% and 99.41-100% for the two genes, respectively. The output of rFlaA and rFlaB expressed by pET32a-flaA-BL21DE3 and pET32J-flaB-BL21DE3 systems was as high as 40-50% of the total bacterial proteins. Both rFlaA and rFlaB were able to combine with the commercial antibodies against whole cell of Hpylori and to induce rabbits to produce specific antibodies with the same 1:2 immunodiffusion titers after the animals were immunized with the two recombinant proteins. Ninety-eight and zero point 4 and 92.80% of the serum samples from 125 patients infected with Hpylori were positive for rFlaA and rFlaB antibodies, respectively. One hundred percent and 98.98% of the 98 tested isolates of H pylori were detectable for rFlaA and rFlaB epitopes, respectively.CONCLUSION: Two prokaryotic expression systems with high efficiency of H pylori flaA and flaB genes were successfully established. The expressed rFlaA and rFlaB showed satisfactory immunoreactivity and antigenicity. High frequencies of FlaA and FlaB expression in different Hpylori clinical strains and the general existence of specific antibodies against FlaA and FlaB in Hpylori infected patients strongly indicate that FlaA and FlaB are excellent antigen candidates for developing H pylori vaccine.

ESTABLISHMENT OF MYCOBACTERIUM SMEGMATIS VACCINE CO- EXPRESSING HELICOBACTER PYLORI UreB AND GREEN FLUORESCENT PROTEIN

Construction of Expression Systems for Flaa and Flab Genes of Helicobacter Pylori and Determination of Immunoreactivity and Antigenicity of Recombinant Proteins.

Recombination of Helicobacter pylori(Hp) OMP Escherichia coli-Mycobacteria Shuttle plasmids and its expression in Mycobacterium smegmatis mc~2 155

Construction of Prokaryotic Expression System of Ltb-Ureb Fusion Gene and Identification of the Recombinant Protein Immunity and Adjuvanticity

Construction of Pmsl As a New Vector for Overexpressing Recombinant Proteins in Mycobacteria

Construction and identification of recombinant Mycobacterium smegmatis vaccine expressing Cysticercus cellulosae cC1 antigen]

Attenuated Salmonella Typhimurium As a Carrier for Prokaryotic and Eukaryotic Expression Vectors

Construction of Prokaryotic Expression System of Ureb Gene from a Clinical Helicobacter Pylori Strain and Identification of the Recombinant Protein Immunity.

Preparation of Recombinant Mycobacterium Smegmatis Pbcg3000-Cfp10-esat6.

Recombinant Mycobacterium Smegmatis Mc(2) 155 Vaccine Expressing Outer Membrane Protein 26 Kda Antigen Affords Therapeutic Protection Against Helicobacter Pylori Infection

Expression of Ureb and Hspa of Helicobacter Pylori in Silkworm Pupae and Identification of Its Immunogenicity

CONSTRUCTION OF SALMONELLA TYPHIMURIUM BIVALENT VACCINE STRAIN EXPRESSING UreA AND KatA

Constructing Shuttle Plasmid Fusion Expressing Ag85B-ESAT-6 on the Surface of Mycobacterium

Expression of Heat Shock Protein 65 of Mycobacterium Tuberculosis and Human IL-2 Fused Gene in Mycobacterium Smegmatis

Construction and Identitication of E.coli-mycobacterium Recombinant Shuttle Vector Expressing Secreted Protein Mpt64 of Mycobacterium Tuberculosis

[Construction of a Dual-Promoter Expression Plasmid Delivered by Salmonella Choleraesuis C500].

The Construction and Sub-Cellular Localization Analysis of Novel Mycobacterial Membrane-Anchored Expression Vector

[Expression and Immunogenicity Analysis of a Recombinant Fusion Protein of V. Cholera Ctb and H. Pylori Ure I].

Construction and Expression of the Fused Gene Vaccine HSP65-IL-2 of Mycobacterium Tuberculosis

Construction and identification of a recombinant attenuated Salmonella typhimurium vaccine strain expressing Helicobacter pylori hpaA gene

Construction and Characterization of Recombinant Attenuated Salmonella Typhimurium Expressing the Baba2/urei Fusion Gene of Helicobacter Pylori.